409 related articles for article (PubMed ID: 25869208)
61. FOXM1 recruits nuclear Aurora kinase A to participate in a positive feedback loop essential for the self-renewal of breast cancer stem cells.
Yang N; Wang C; Wang Z; Zona S; Lin SX; Wang X; Yan M; Zheng FM; Li SS; Xu B; Bella L; Yong JS; Lam EW; Liu Q
Oncogene; 2017 Jun; 36(24):3428-3440. PubMed ID: 28114286
[TBL] [Abstract][Full Text] [Related]
62. FoxM1 transactivates PTTG1 and promotes colorectal cancer cell migration and invasion.
Zheng Y; Guo J; Zhou J; Lu J; Chen Q; Zhang C; Qing C; Koeffler HP; Tong Y
BMC Med Genomics; 2015 Aug; 8():49. PubMed ID: 26264222
[TBL] [Abstract][Full Text] [Related]
63. FOXM1 promotes reprogramming of glucose metabolism in epithelial ovarian cancer cells via activation of GLUT1 and HK2 transcription.
Wang Y; Yun Y; Wu B; Wen L; Wen M; Yang H; Zhao L; Liu W; Huang S; Wen N; Li Y
Oncotarget; 2016 Jul; 7(30):47985-47997. PubMed ID: 27351131
[TBL] [Abstract][Full Text] [Related]
64. Downregulation of FOXO3a by DNMT1 promotes breast cancer stem cell properties and tumorigenesis.
Liu H; Song Y; Qiu H; Liu Y; Luo K; Yi Y; Jiang G; Lu M; Zhang Z; Yin J; Zeng S; Chen X; Deng M; Jia X; Gu Y; Chen D; Zheng G; He Z
Cell Death Differ; 2020 Mar; 27(3):966-983. PubMed ID: 31296961
[TBL] [Abstract][Full Text] [Related]
65. Foxm1 transcription factor is required for the initiation of lung tumorigenesis by oncogenic Kras(G12D.).
Wang IC; Ustiyan V; Zhang Y; Cai Y; Kalin TV; Kalinichenko VV
Oncogene; 2014 Nov; 33(46):5391-6. PubMed ID: 24213573
[TBL] [Abstract][Full Text] [Related]
66. The critical role of dysregulated FOXM1-PLAUR signaling in human colon cancer progression and metastasis.
Li D; Wei P; Peng Z; Huang C; Tang H; Jia Z; Cui J; Le X; Huang S; Xie K
Clin Cancer Res; 2013 Jan; 19(1):62-72. PubMed ID: 23136192
[TBL] [Abstract][Full Text] [Related]
67. Adenovirus-mediated RNA interference targeting FOXM1 transcription factor suppresses cell proliferation and tumor growth of nasopharyngeal carcinoma.
Chen H; Yang C; Yu L; Xie L; Hu J; Zeng L; Tan Y
J Gene Med; 2012 Apr; 14(4):231-40. PubMed ID: 22359343
[TBL] [Abstract][Full Text] [Related]
68. Transcriptional Repression by FoxM1 Suppresses Tumor Differentiation and Promotes Metastasis of Breast Cancer.
Kopanja D; Chand V; O'Brien E; Mukhopadhyay NK; Zappia MP; Islam ABMMK; Frolov MV; Merrill BJ; Raychaudhuri P
Cancer Res; 2022 Jul; 82(13):2458-2471. PubMed ID: 35583996
[TBL] [Abstract][Full Text] [Related]
69. USP18 promotes breast cancer growth by upregulating EGFR and activating the AKT/Skp2 pathway.
Tan Y; Zhou G; Wang X; Chen W; Gao H
Int J Oncol; 2018 Jul; 53(1):371-383. PubMed ID: 29749454
[TBL] [Abstract][Full Text] [Related]
70. Epigenetic modulation of FOXM1-gene interacting network by BET inhibitors in breast cancer.
Pérez-Peña J; Győrffy B; Amir E; Pandiella A; Ocaña A
Breast Cancer Res Treat; 2018 Dec; 172(3):725-732. PubMed ID: 30206781
[TBL] [Abstract][Full Text] [Related]
71. The suppression of FOXM1 and its targets in breast cancer xenograft tumors by siRNA.
Wang M; Gartel AL
Oncotarget; 2011 Dec; 2(12):1218-26. PubMed ID: 22203467
[TBL] [Abstract][Full Text] [Related]
72. Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma.
Zhang X; Lv QL; Huang YT; Zhang LH; Zhou HH
J Exp Clin Cancer Res; 2017 Aug; 36(1):105. PubMed ID: 28784180
[TBL] [Abstract][Full Text] [Related]
73. Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progression.
Nandi I; Smith HW; Sanguin-Gendreau V; Ji L; Pacis A; Papavasiliou V; Zuo D; Nam S; Attalla SS; Kim SH; Lusson S; Kuasne H; Fortier AM; Savage P; Martinez Ramirez C; Park M; Katzenellenbogen JA; Katzenellenbogen BS; Muller WJ
J Clin Invest; 2023 Apr; 133(7):. PubMed ID: 36795481
[TBL] [Abstract][Full Text] [Related]
74. Identification of FOXM1 as a specific marker for triple‑negative breast cancer.
Tan Y; Wang Q; Xie Y; Qiao X; Zhang S; Wang Y; Yang Y; Zhang B
Int J Oncol; 2019 Jan; 54(1):87-97. PubMed ID: 30365046
[TBL] [Abstract][Full Text] [Related]
75. Delphinidin-3-glucoside suppresses breast carcinogenesis by inactivating the Akt/HOTAIR signaling pathway.
Yang X; Luo E; Liu X; Han B; Yu X; Peng X
BMC Cancer; 2016 Jul; 16():423. PubMed ID: 27388461
[TBL] [Abstract][Full Text] [Related]
76. Apigenin, a Partial Antagonist of the Estrogen Receptor (ER), Inhibits ER-Positive Breast Cancer Cell Proliferation through Akt/FOXM1 Signaling.
Pham TH; Page YL; Percevault F; Ferrière F; Flouriot G; Pakdel F
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466512
[TBL] [Abstract][Full Text] [Related]
77. Integrating bioinformatics and experimental models to investigate the mechanism of the chelidonine-induced mitotic catastrophe via the AKT/FOXO3/FOXM1 axis in breast cancer cells.
Li H; Tang X; Sun Z; Qu Z; Zou X
Biomol Biomed; 2024 May; 24(3):560-574. PubMed ID: 37976368
[TBL] [Abstract][Full Text] [Related]
78. Reciprocal Regulation Between Forkhead Box M1/NF-κB and Methionine Adenosyltransferase 1A Drives Liver Cancer.
Li Y; Lu L; Tu J; Zhang J; Xiong T; Fan W; Wang J; Li M; Chen Y; Steggerda J; Peng H; Chen Y; Li TWH; Zhou ZG; Mato JM; Seki E; Liu T; Yang H; Lu SC
Hepatology; 2020 Nov; 72(5):1682-1700. PubMed ID: 32080887
[TBL] [Abstract][Full Text] [Related]
79. Mammalian target of rapamycin repression by 3,3'-diindolylmethane inhibits invasion and angiogenesis in platelet-derived growth factor-D-overexpressing PC3 cells.
Kong D; Banerjee S; Huang W; Li Y; Wang Z; Kim HR; Sarkar FH
Cancer Res; 2008 Mar; 68(6):1927-34. PubMed ID: 18339874
[TBL] [Abstract][Full Text] [Related]
80. FOXM1 cistrome predicts breast cancer metastatic outcome better than FOXM1 expression levels or tumor proliferation index.
Yau C; Meyer L; Benz S; Vaske C; Scott G; Egan B; Labhart P; Pourmand N; Benz CC
Breast Cancer Res Treat; 2015 Nov; 154(1):23-32. PubMed ID: 26456572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
